Jeremy G Chadwick
CIK 1388406 · Chief Operating Officer · last filed 2026-05-27
Jeremy G Chadwick is a Chief Operating Officer who has filed 31 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for KYMR, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$15.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
KYMR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN, MA 02472
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | Chief Operating Officer | 48,297 | $104.78 | $5.06M | -$15.81M | 12 | 2026-05-27 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Sr. VP, Pgm Mgmt and Clin Ops | 23,761 | — | — | -$28.4K | 5 | 2010-03-03 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | KYMR | Notice (144) | −66,893 | -$5.85M | EDGAR |
| 2026-05-27 | KYMR | Sell (S) | −17,184 | -$1.37M | EDGAR |
| 2026-05-26 | KYMR | Notice (144) | −13,130 | -$1.04M | EDGAR |
| 2026-05-26 | KYMR | Notice (144) | −4,054 | -$317.9K | EDGAR |
| 2026-04-24 | KYMR | Mixed | — | -$15.3K | EDGAR |
| 2026-04-22 | KYMR | Notice (144) | −300 | -$26.4K | EDGAR |
| 2026-04-16 | KYMR | Mixed | — | -$364.2K | EDGAR |
| 2026-04-15 | KYMR | Notice (144) | −1,300 | -$116.8K | EDGAR |
| 2026-04-14 | KYMR | Notice (144) | −5,251 | -$464.9K | EDGAR |
| 2026-04-01 | KYMR | Notice (144) | −14,640 | -$1.22M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.